Akums Drugs Ltd: ₹344 Cr PAT, 2137% Profit Growth TTM – CDMO With a Comeback Script
🧠 At a Glance
Akums Drugs is the behind-the-scenes pharma ninja — manufacturing drugs for everyone but branding them for no one. As a Contract Development and Manufacturing Organization (CDMO), it’s the ghostwriter of the Indian pharma world. After a revenue dip and margin crisis in FY22–24, Akums pulled off a PAT of ₹344 Cr in FY25 on ₹4,118 Cr revenue. ROE is back at 17.2%, P/E is a modest 23.7, and guess what? The debt is almost gone. Someone give their CFO a standing ovation (or a crocin, whichever’s handy).
1. Introduction – From Losses to Lab Coats
Akums started in 2004, made its name ghost-manufacturing for India’s pharma giants, then nearly ghosted investors during its FY22 margin crisis. But now? It’s rising like a phoenix out of the Petri dish.
In FY22, they made a loss of ₹251 Cr. In FY23, they made just ₹1 Cr. But FY25? Boom — ₹344 Cr. What happened? Efficiency, cost control, scale, and probably a few Hail Mary contracts. Oh, and they now have an EUR 200 million CDMO deal in place.
2. Business Model – WTF Do They Even Do?
Akums is a CDMO — meaning it doesn’t make its own brands but manufactures products for pharma companies globally. Think of it like TCS, but for pills.
Segments:
Solid Orals (tablets, capsules)
Injectables (vials, ampoules, dry powder)
Topicals (creams, gels)
Eye/Ear drops, nutraceuticals (gummies too!)
Revenue sources:
Domestic contract manufacturing
Export contracts (now expanding fast)
Custom R&D and formulation development
Client list includes both Indian pharma giants and overseas formulators. The model is scalable, asset-heavy, but less risky than branding — you get paid for the lab, not the label.
3. Financials Overview – The Comeback Kid
Source table
FY25
₹ Cr
Revenue
4,118
EBITDA
465
EBITDA Margin
11.3%
PAT
344
EPS
₹21.49
ROE
17.2%
ROCE
16.2%
🎯 Fresh P/E = ₹487 ÷ ₹21.49 = 22.7x
Not bad for a pharma CDMO turning around with clean cash flows, low debt, and no brand risk. Margin recovery is visible, and PAT jumped off the ventilator.
